Ignite Creation Date:
2025-12-24 @ 7:44 PM
Ignite Modification Date:
2026-01-25 @ 6:08 AM
Study NCT ID:
NCT02151903
Status:
TERMINATED
Last Update Posted:
2020-11-27
First Post:
2014-05-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Participants With B-cell NHL
Sponsor:
Alopexx Oncology, LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
AO-101-EXT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None